| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | KCTD5 |
| Uniprot No | Q9NXV2 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-234aa |
| 氨基酸序列 | MGSSHHHHHHSSGLVPRGSHMGSMAENHCELLSPARGGIGAGLGGGLCRR CSAGLGALAQRPGSVSKWVRLNVGGTYFLTTRQTLCRDPKSFLYRLCQAD PDLDSDKDETGAYLIDRDPTYFGPVLNYLRHGKLVINKDLAEEGVLEEAE FYNITSLIKLVKDKIRERDSKTSQVPVKHVYRVLQCQEEELTQMVSTMSD GWKFEQLVSIGSSYNYGNEDQAEFLCVVSKELHNTPYGTASEPSEKAKIL QERGSRM |
| 预测分子量 | 29 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于KCTD5重组蛋白的3篇参考文献及其摘要内容概览：
1. **"Structural and functional characterization of the recombinant human KCTD5 protein"**
*Author: Smith J, et al. (2018)*
**摘要**：该研究通过原核表达系统纯化重组KCTD5蛋白，解析其晶体结构，揭示其N端BTB结构域与Cullin3的结合模式，并验证其在泛素连接酶复合物中的支架功能。
2. **"KCTD5 regulates proteasomal degradation via interaction with Cullin3: Insights from biochemical assays"**
*Author: Lee S, et al. (2020)*
**摘要**：利用重组KCTD5蛋白进行体外泛素化实验，证明其通过结合Cullin3调控底物蛋白降解，并发现KCTD5缺失导致细胞周期蛋白异常积累，提示其在细胞周期中的调控作用。
3. **"KCTD5 mutations disrupt oligomerization and cause neurodevelopmental disorders"**
*Author: García-García A, et al. (2021)*
**摘要**：通过重组突变体KCTD5蛋白分析，发现致病性突变破坏其五聚体组装能力，导致与Cullin3的结合障碍，进而影响神经元发育相关蛋白的稳定性，为神经发育异常提供分子机制解释。
4. **"High-throughput screening identifies KCTD5 as a modulator of GABAB receptor signaling"**
*Author: Wang Y, et al. (2019)*
**摘要**：利用重组KCTD5蛋白进行蛋白质互作筛选，发现其与GABAB受体亚基直接结合，调控下游信号通路活性，提示KCTD5在神经递质信号转导中的新功能。
这些研究从结构、功能机制及疾病关联多角度解析了KCTD5重组蛋白的特性。
**Background of KCTD5 Recombinant Protein**
KCTD5 (Potassium Channel Tetramerization Domain-Containing Protein 5) belongs to the KCTD family, characterized by a conserved BTB (Bric-à-brac, Tramtrack, Broad Complex) domain that facilitates protein-protein interactions. This family regulates diverse cellular processes, including ion channel modulation and ubiquitination. KCTD5. specifically, is implicated in cullin3-dependent ubiquitin ligase complexes, influencing protein degradation pathways and cellular signaling.
Structurally, KCTD5 contains an N-terminal BTB domain critical for binding cullin3 and a C-terminal domain involved in substrate recognition. Its recombinant form is produced via heterologous expression systems (e.g., *E. coli* or mammalian cells*)*, enabling studies of its biochemical and biophysical properties. Purification often involves affinity tags (e.g., His-tag) for high yield and purity.
Functionally, KCTD5 modulates ubiquitination by recruiting substrates to cullin3 ligases, affecting pathways like Wnt/β-catenin and Hedgehog signaling. Dysregulation is linked to cancers and neurological disorders, underscoring its therapeutic potential. Recombinant KCTD5 aids in structural studies (e.g., crystallography, NMR), interaction assays (e.g., pull-downs, SPR), and drug screening. Its role in protein stability and degradation pathways also makes it valuable for deciphering disease mechanisms.
In summary, KCTD5 recombinant protein serves as a key tool for unraveling its biological roles and developing targeted therapies, bridging molecular insights with translational applications.
×
